Media Library

Pam Skurkay, Dianna Shafer, and Angela Hunter talk about following patients taking bisphosphonates and those who take Xgeva.
Pam Skurkay talks about when providers consider prescribing one class of drugs versus another with factors that include the patient's insurance and overall health.
Pam Skurkay talks about why taking an injectable is seen as beneficial for patient preferences.
Pam Skurkay talks about when she and other nurses began using a medicine to treat bone-related health issues and how they eventually allowed outside medical offices the pre-authorization to use it.
Dianna Shafer and Angela Hunter talk about the DEXA scan results, and how the implementation of a specific therapy helped decrease bone-related issues.
Dianna Shafer talks about how bone health goes with prostate health treatment, and trying to avoid skeletal health events.
Pam Skurkay, Dianna Shafer, and Angela Hunter discuss the positive scan results they are seeing post-immunotherapy when using denosumab.
Jennifer Brown, MD, PhD, expanded upon the results of her and her colleagues’ study of the hepatotoxic effects of idelalisib, particularly as frontline treatment of younger patients with chronic lymphocytic leukemia, which was presented at the 57th American Society of Hematology Annual Meeting & Exposition.
William A. Zellmer, BPharm, MPH, discusses how the 4th edition of the American Society of Health-System Pharmacists (ASHP) Foundation’s Pharmacy Forecast serves to improve the effectiveness of leaders in hospital and health-system pharmacy practice.
Lindsey B. Amerine, PharmD, MS, BCPS, discussed her practice’s process for formulary management and procurement of oncology medications at the 11th annual Hematology/Oncology Pharmacy Association conference.
Page 3 of 4
Results 21 - 30 of 33